Profile
AAPG VRTX ALNY REGN ARGX SGEN
Company Name Ascentage Pharma Group International Vertex Pharmaceuticals Incorporated Alnylam Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc. argenx SE Seagen Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $3.52B $101.65B $58.93B $57.87B $45.27B $43.15B
Employees 0.57K 6.10K 2.23K 15.16K 1.60K 3.26K
CEO Dajun Yang Reshma Kewalramani FASN, Yvonne L. Greenstreet Leonard S. Schleifer Timothy Van Hauwermeiren EMBA, David R. Epstein
Ratings
AAPG VRTX ALNY REGN ARGX SGEN
Quant Rating Score 1 4 1 4 4 3
Quant Rating Strong Sell Buy Strong Sell Buy Buy Neutral
Trading
AAPG VRTX ALNY REGN ARGX SGEN
Last Close $37.83 $381.87 $449.58 $555.51 $711.09 $228.74
High 52 $49.15 $516.74 $482.13 $1051.24 $768 $228.74
Low 52 $17.2 $366.54 $224.58 $482.92 $520.52 $228.74
Price vs. 52 Week High -23.03 % -26.1 % -6.75 % -47.16 % -7.41 % 0 %
Price vs. 52 Week Low 119.94 % 4.18 % 100.19 % 15.03 % 36.61 % 0 %
Total Return
AAPG VRTX ALNY REGN ARGX SGEN
1 Month Return -11.5 % -1.37 % -0.3 % -5.45 % 0.42 % 0 %
3 Month Return -7.3 % -13.88 % 41.33 % 6.65 % 26.86 % 0 %
6 Month Return 104.49 % -23.67 % 67 % -13.22 % 21.83 % 0 %
9 Month Return 0 % -7.01 % 85.39 % -22.49 % 12.51 % 0 %
YTD Return 0 % -5.17 % 91.06 % -22.02 % 15.62 % 0 %
1 Year Return 0 % -17.55 % 63.74 % -46.58 % 35.55 % 0 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
AAPG VRTX ALNY REGN ARGX SGEN
Dividend Yield Percentage (TTM) - - - 0.48 % - -
Dividend Paid and Capex Coverage Ration (TTM) -4.58 % 11.09 % -0.43 % 4.37 % -44.32 % -5.87 %
Dividend Per Share (TTM) - - - 2.64 % - -
Payout Ratio (TTM) - - - 4.18 % - -
Profitability
AAPG VRTX ALNY REGN ARGX SGEN
Gross Profit Margin TTM 97.03 % 86.11 % 83.64 % 81.98 % 65.32 % 79.1 %
Return on Assets TTM -15.49 % 15.13 % -6.99 % 11.67 % 15.06 % -16.61 %
Return on Equity TTM -78.68 % 22.14 % -274.21 % 15.11 % 18.96 % -20.8 %
Return on Capital Employed TTM -26.1 % 19.72 % -5.52 % 11.45 % 5.04 % -21.46 %
Net Income Per EBT TTM 102.58 % 83.16 % 84.06 % 91.46 % 237.3 % 101.33 %
EBT Per Ebit TTM 104.34 % 111.48 % 210.66 % 123.23 % 147.38 % 98.26 %
EBIT Per Revenue TTM -38.63 % 34.36 % -7.32 % 27.83 % 13.47 % -31.24 %
Cash Flow To Debt Ratio TTM -6.67 % 251.83 % -1.2 % 175.35 % -175.92 % -1043.73 %
Receivables Turnover TTM 9.9 6.03 4.34 2.53 1.91 3.91
Payables Turnover TTM 0.32 0.43 3.93 3.54 0.88 1.97
Inventory Turnover TTM 4.41 1.06 5.62 0.8 2.21 0.96
Fixed Asset Turnover TTM 108.26 % 431.08 % 355.68 % 293.64 % 5009.77 % 665.41 %
Asset Turnover TTM 37.46 % 47.51 % 53.92 % 37.19 % 31.97 % 53.41 %
Operating Cash Flow Per Share TTM -0.36 14.98 -0.12 45.13 -1.07 -2.46
Free Cash Flow Per Share TTM -0.43 13.63 -0.4 36.58 -1.09 -2.88
Cash Per Share TTM 395.87 % 3036 % 2203.63 % 7107.14 % 5536.58 % 939.52 %
Operating Cash Flow Sales Ratio TTM -11.36 % 33.68 % -0.63 % 33.37 % -3.31 % -23.12 %
Free Cash Flow Operating Cash Flow Ratio TTM 121.81 % 90.99 % 335.21 % 81.05 % 102.26 % 117.04 %
Cash Flow Coverage Ratios TTM -6.67 % 251.83 % -1.2 % 175.35 % -175.92 % -1043.73 %
Price To Free Cash Flows Ratio TTM -185 29.05 -1131.36 15.05 -582.34 -81.26
Price To Operating Cash Flows Ratio TTM -757.2 26.46 -3751.83 12.31 -690.34 -93.1
Price Cash Flow Ratio TTM -757.2 26.46 -3751.83 12.31 -690.34 -93.1
Income Statement (TTM)
AAPG VRTX ALNY REGN ARGX SGEN
Revenue $0.98B $11.02B $2.25B $14.2B $2.19B $1.96B
Gross Profit $0.95B $9.49B $1.92B $11.75B $1.96B $1.55B
Gross Profit Ratio 97.03% 86.11% 85.62% 82.74% 89.62% 79.1%
EBITDA $-0.24B $0.49B $-0.18B $5.32B $0.11B $-0.62B
Net Income $-0.41B $-0.54B $-0.28B $4.41B $0.83B $-0.61B
EPS Diluted -0.75 -2.08 -2.16 38.34 12.78 -3.3
Balance Sheet (MRQ)
AAPG VRTX ALNY REGN ARGX SGEN
Long Term Debt $0.87B $1.66B $1.25B $2.7B $0.03B $0.04B
Total Liabilities $2.34B $6.12B $4.17B $8.41B $0.7B $0.87B
Total Equity $0.27B $16.41B $0.07B $29.35B $5.5B $2.8B
Total Investments $0.03B $6.65B $1.73B $15.42B $1.93B $1.42B
Total Debt $1.67B $1.75B $1.3B $2.7B $0.04B $0.04B
Total Assets $2.62B $22.53B $4.24B $37.76B $6.2B $3.67B
Cash Flow Statement (TTM)
AAPG VRTX ALNY REGN ARGX SGEN
Net Income $-0.4B $-0.54B $-0.28B $4.41B $0.83B $-0.61B
Inventory $0.01B $-0.52B $0.01B $-0.62B $-0.1B $-0.23B
Dividends Paid $0B $0B $0B $0B $0B $0B
Operating Cash Flow $-0.11B $-0.49B $-0.01B $4.42B $-0.08B $-0.45B
Capital Expenditure $-0.02B $-0.3B $-0.03B $-0.76B $-0.07B $-0.08B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AARD Aardvark Therapeutics, Inc. Common Stock 13.2
ABCL AbCellera Biologics Inc. 4.745
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.43
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 1.43
ABPWW 0.0231
ABSI Absci Corporation 2.725
ABUS Arbutus Biopharma Corporation 4.41
ABVC ABVC BioPharma, Inc. 3.16
ABVX Abivax SA American Depositary Shares 82.77
ACAD ACADIA Pharmaceuticals Inc. 21.04
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 0.8364
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 3
ACIU AC Immune SA 2.84
ACLX Arcellx, Inc. 79.69
ETFs With Exposure to AAPG
Ticker ETF Name Weight Percentage Price
PGJ Invesco Golden Dragon China ETF 0.022 32.83
BOUT Innovator IBD Breakout Opportunities ETF 6.09 38.725
CANC Tema Oncology ETF 0.54 27.2399
Unlock